Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Suppression of Map Kinases Inhibits Microglial Activation and Attenuates Neuronal Cell Death Induced by Alpha-Synuclein Protofibrils

Författare

  • H. Wilms
  • P. Rosenstiel
  • Marina Romero-Ramos
  • A. Arlt
  • H. Schaefer
  • D. Seegert
  • P. J. Kahle
  • S. Odoy
  • J. H. Claasen
  • C. Holzknecht
  • L. O. Brandenburg
  • G. Deuschl
  • S. Schreiber
  • Deniz Kirik
  • R. Lucius

Summary, in English

alpha-Synuclein (alpha-Syn) accounts, as a major component of Lewy bodies (LB), for the filamentous deposits in many cases of neurodegenerative diseases. Yet, little is known about the molecular mechanisms of neuronal loss in these diseases. The correlation between alpha-Syn oligomerization/aggregation and pathologies raises the key question of which molecular form of alpha-Syn (i.e. monomeric alpha-Syn, protofibrils or mature fibrils) represents the damage-inducing culprit in the scenario of synucleinopathies. We show that human alpha-Syn protofibrils (PFs) are potent activators of parallel proinflammatory signalling pathways (p38 and ERK1/2 MAP kinases and NF-kappa B) in microglial cells in vitro. Furthermore, stereotactic injection of alpha-Syn PFs into the substantia nigra of adult rats leads to a profound activation of microglia and adjacent neuronal cell loss, which can be attenuated by the MAP kinase inhibitor semapimod. We propose that the neurodegenerative process of alpha-synucleinopathies involves microglial activation through alpha-Syn released or extruded from cells with pathogenic alpha-Syn metabolism. Compounds that inhibit the MAPK/NF-kappa B pathways might be a promising pharmacological strategy for the treatment of the inflammatory component of synucleinopathies including PD.

Publiceringsår

2009

Språk

Engelska

Sidor

897-909

Publikation/Tidskrift/Serie

International Journal of Immunopathology and Pharmacology

Volym

22

Issue

4

Dokumenttyp

Artikel i tidskrift

Förlag

Biolife SAS

Ämne

  • Neurosciences

Nyckelord

  • microglia
  • neuroinflammation
  • Parkinson's disease
  • alpha-synuclein
  • NF-kappa B

Status

Published

Forskningsgrupp

  • Brain Repair and Imaging in Neural Systems (BRAINS)

ISBN/ISSN/Övrigt

  • ISSN: 0394-6320